• Step change in profitability and cash generation in 2025, with acceleration expected in 2026
• Underlying revenue growth of 6.5% versus 2024, with consultation growth returning in H2 FY 25 (3.4%)
• Underlying EBITDA of £5.3m in 2025 representing a 13.9% margin compared with £0.1m in 2024

Doctor Care Anywhere Group PLC reported its Preliminary Full Year results for the year ended 31 December 2025. The company achieved a step change in profitability and cash generation in 2025, with acceleration expected in 2026. Underlying revenue grew by 6.5% versus 2024, with consultation growth returning in H2 FY 25 (3.4%). The company's underlying contribution margin improved to 43.5%, up 5.2ppt on 2024, driven by price increases, clinical mix expansion, and improved operational efficiencies. Underlying EBITDA increased substantially to £5.3m, up from £0.1m in FY24, prominently driven by the improvements to contribution and non-operating costs. Net underlying profit for FY25 increased by 230.2%, or £4.9m, compared with FY24, due to ongoing growth and a focus on productivity improvements and margin expansion. The company ended the year in a strong financial position with £6.6m in cash and a £10.6m convertible loan facility. 2025 was a transformational year for Doctor Care Anywhere, with renewed consistent consultation growth, new client wins, new clinical treatment pathways, and product development focused on improving the user experience. The company reiterated its medium-term targets, including revenue doubling over 3-5 years and a 15% EBITDA margin.

Management reiterates medium-term targets, including revenue doubling over 3-5 years and a 15% EBITDA margin.

The company moves into the year ahead building on this momentum, deepening partnerships, accelerating innovation and staying true to its mission. The company is confident and well-positioned for continued growth.